期刊
STROKE
卷 41, 期 8, 页码 E537-E540出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.110.580274
关键词
arteriovenous malformations; endovascular treatment; neuroradiology; neurosurgery; radiotherapy; randomized controlled trials
资金
- Medical Research Council [G108/613] Funding Source: researchfish
- Medical Research Council [G108/613] Funding Source: Medline
- NINDS NIH HHS [U01 NS051483-03, U01 NS051483] Funding Source: Medline
- MRC [G108/613] Funding Source: UKRI
Background and Purpose-Report on the status of an on-going National Institutes of Neurological Disorders and Stroke (NINDS)-supported clinical trial of management of unbled brain arteriovenous malformations. Summary of Review-Begun in April 2007 with 3 centers, the trial has grown to 65 centers, and has randomized 124 patients through mid-June 2010 en route to the planned 400. The current literature continues to support the rationale for the trial. Conclusions-ARUBA is steadily approaching its monthly randomization goals and has already reached the number needed to test the maximum published interventional complication rates against the minimum hemorrhage rates for natural history. (Stroke. 2010; 41: e537-e540.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据